Wekking D, Senevirathne TH, Pearce JL, et al. The impact of COVID-19 on cancer patients. Cytokine & growth factor reviews. 2023. doi:10.1016/j.cytogfr.2023.11.004
Publications
Liu Y, Altreuter J, Bodapati S, et al. Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities. Cell genomics. 2023;4(1):100444. doi:10.1016/j.xgen.2023.100444
Shi M, Tanikawa C, Munter HM, et al. Genotype imputation accuracy and the quality metrics of the minor ancestry in multi-ancestry reference panels. Briefings in bioinformatics. 2023;25(1). doi:10.1093/bib/bbad509
Weber JK, Morrone JA, Kang SG, et al. Unsupervised and supervised AI on molecular dynamics simulations reveals complex characteristics of HLA-A2-peptide immunogenicity. Briefings in bioinformatics. 2023;25(1). doi:10.1093/bib/bbad504
Krainc D, Martin WJ, Casey B, et al. Shifting the trajectory of therapeutic development for neurological and psychiatric disorders. Science translational medicine. 2023;15(720):eadg4775. doi:10.1126/scitranslmed.adg4775
Wilton DK, Mastro K, Heller MD, et al. Author Correction: Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease. Nature medicine. 2023;29(11):2958. doi:10.1038/s41591-023-02663-3
Tanigawa Y, Kellis M. Power of inclusion: Enhancing polygenic prediction with admixed individuals. American journal of human genetics. 2023;110(11):1888-1902. doi:10.1016/j.ajhg.2023.09.013
Martin BJE, Ablondi EF, Goglia C, Mimoso CA, Espinel-Cabrera PR, Adelman K. Global identification of SWI/SNF targets reveals compensation by EP400. Cell. 2023;186(24):5290-5307.e26. doi:10.1016/j.cell.2023.10.006
Schaffner SF, Badiane A, Khorgade A, et al. Malaria surveillance reveals parasite relatedness, signatures of selection, and correlates of transmission across Senegal. Nature communications. 2023;14(1):7268. doi:10.1038/s41467-023-43087-4
Linder SJ, Bernasocchi T, Martinez-Pastor B, et al. Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells. Nature metabolism. 2023. doi:10.1038/s42255-023-00919-3